72 results
·
45ms
·
Sources: EU EUDAMED, US FDA
Filters
FDA Classification
×
Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer
FDA classification
FDA Class 2
·Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer
P2psa
FDA classification
FDA Class 3
·P2psa
Radioassay, Intrinsic Factor Blocking Antibody
FDA classification
FDA Class 2
·Radioassay, Intrinsic Factor Blocking Antibody
Assay To Measure Pct To Aid In The Risk Assessment Of Critically Ill Patients On Their First Day Of Icu Admission
FDA classification
FDA Class 2
·Assay To Measure Pct To Aid In The Risk Assessment Of Critically Ill Patients On Their First Day Of Icu Admission
Electrophoretic Separation, Alkaline Phosphatase Isoenzymes
FDA classification
FDA Class 2
·Electrophoretic Separation, Alkaline Phosphatase Isoenzymes
Kit, Test, Alpha-Fetoprotein For Neural Tube Defects
FDA classification
FDA Class 3
·Kit, Test, Alpha-Fetoprotein For Neural Tube Defects
Enzyme Immunoassay, Inhibin-A
FDA classification
FDA Class 1
·Enzyme Immunoassay, Inhibin-A
Assay, Erythropoietin
FDA classification
FDA Class 2
·Assay, Erythropoietin
Immunochemical, Thyroglobulin Autoantibody
FDA classification
FDA Class 2
·Immunochemical, Thyroglobulin Autoantibody
Counter, Urine Particle
FDA classification
FDA Class 2
·Counter, Urine Particle
System, Test, Thyroglobulin
FDA classification
FDA Class 2
·System, Test, Thyroglobulin
Test, Prostate Specific Antigen, Free, (Noncomplexed) To Distinguish Prostate Cancer From Benign Conditions
FDA classification
FDA Class 3
·Test, Prostate Specific Antigen, Free, (Noncomplexed) To Distinguish Prostate Cancer From Benign Conditions
Radioimmunoassay, Thyroxine-Binding Globulin
FDA classification
FDA Class 2
·Radioimmunoassay, Thyroxine-Binding Globulin
Total, Prostate Specific Antigen (Noncomplexed & Complexed) For Detection Of Prostate Cancer
FDA classification
FDA Class 3
·Total, Prostate Specific Antigen (Noncomplexed & Complexed) For Detection Of Prostate Cancer
Radioimmunoassay (Two-Site Solid Phase), Ferritin
FDA classification
FDA Class 2
·Radioimmunoassay (Two-Site Solid Phase), Ferritin
System, Test, Carbohydrate Antigen (Ca19-9), For Monitoring And Management Of Pancreatic Cancer
FDA classification
FDA Class 2
·System, Test, Carbohydrate Antigen (Ca19-9), For Monitoring And Management Of Pancreatic Cancer
Counter, Cell, Automated (Particle Counter)
FDA classification
FDA Class 2
·Counter, Cell, Automated (Particle Counter)
Radioimmunoassay, Cortisol
FDA classification
FDA Class 2
·Radioimmunoassay, Cortisol
Radioimmunoassay, Estriol
FDA classification
FDA Class 1
·Radioimmunoassay, Estriol
Enzyme Immunoassay, Digoxin
FDA classification
FDA Class 2
·Enzyme Immunoassay, Digoxin